CD8A and neoplasm: The degree of infiltration of CD8+ tumor-infiltrating lymphocytes (TILs) is a crucial predictor of the efficacy of immunotherapy and patient prognosis and helps in the precise selection of appropriate treatment regimens for personalized medicine (27).